Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Gain Therapeutics (GANX) Asset Utilization Ratio (2021 - 2023)

Historic Asset Utilization Ratio for Gain Therapeutics (GANX) over the last 3 years, with Q4 2023 value amounting to 0.0.

  • Gain Therapeutics' Asset Utilization Ratio fell 3687.24% to 0.0 in Q4 2023 from the same period last year, while for Dec 2023 it was 0.0, marking a year-over-year decrease of 3687.24%. This contributed to the annual value of 0.0 for FY2023, which is 4182.66% down from last year.
  • As of Q4 2023, Gain Therapeutics' Asset Utilization Ratio stood at 0.0, which was down 3687.24% from 0.0 recorded in Q3 2023.
  • Over the past 5 years, Gain Therapeutics' Asset Utilization Ratio peaked at 0.01 during Q1 2023, and registered a low of 0.0 during Q1 2021.
  • Over the past 3 years, Gain Therapeutics' median Asset Utilization Ratio value was 0.0 (recorded in 2021), while the average stood at 0.0.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first skyrocketed by 46084.83% in 2022, then plummeted by 5401.7% in 2023.
  • Over the past 3 years, Gain Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.0 in 2021, then soared by 32.09% to 0.01 in 2022, then crashed by 36.87% to 0.0 in 2023.
  • Its Asset Utilization Ratio was 0.0 in Q4 2023, compared to 0.0 in Q3 2023 and 0.0 in Q2 2023.